Bulldog Investors’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

Bulldog Investors’s Portfolio PKBOW Stock Details PKBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,500	Closed	-$9K	–	376
2021 Q4	$9K	Hold	12,500	–	–	﹤0.01%	284
2021 Q3	$8K	Hold	12,500	–	–	﹤0.01%	257
2021 Q2	$9K	Buy	+12,500	New	+$9.52K	﹤0.01%	245

Other funds holding PKBOW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.39% 1-Year Est. Return

Bulldog Investors's PKBOW Position: Q1 2022 in Review

Bulldog Investors sold out of Peak Bio, Inc. Warrant (PKBOW) in Q1 2022, closing a stake of 12,500 shares — an estimated $9K sold.

Bulldog Investors first reported a position in PKBOW in Q2 2021 and held it in 3 quarters. The position peaked at $9K in Q4 2021. 16 funds tracked by Wall St. Rank hold PKBOW as of Q1 2022.

Bulldog Investors reported no remaining Peak Bio, Inc. Warrant position as of Q1 2022 after selling out during the quarter.
Bulldog Investors sold 12,500 Peak Bio, Inc. Warrant shares in Q1 2022, an estimated $9K.
Bulldog Investors first reported a position in Peak Bio, Inc. Warrant in Q2 2021 and held it in 3 quarters.
Bulldog Investors's Peak Bio, Inc. Warrant position peaked at $9K in Q4 2021.
16 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q1 2022.

Based on Bulldog Investors's 13F filing for Q1 2022, filed 13 May 2022.